Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Stevens

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacy and Pharmacology|December 1, 1981
A new light on the photo-decomposition of the antitumour drug DTICJ K Horton, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Azidoacridines; potential nucleic acid mutagensA C Mair, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1973
Medicinal nitro-compounds. 1. Photo-rearrangement of N-aryl-2-nitrobenzamidesB C Gunn, M F Stevens
The Journal of Pharmacy and Pharmacology|December 1, 1979
Search for drug interactions between the antitumour agent DTIC and other cytotoxic agents [proceedings]J K Horton, M F Stevens
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
From triazines and triazenes to temozolomideM F Stevens, E S Newlands
British Medical Journal|August 27, 2010
New Stabilizer for Schick ToxinA T Glenny, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1975
Triazines and related products. Part XV. 2,4-Diaminopyrimidines and 2-aminopyrimidin-4(3H)-ones bearing 1,2,3-benzotriazinyl groups as potential dihydrofolic reductase inhibitorsT B Brown, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Triazines and related products. IX. Potential irreversible dihydrofolate reductase inhibitors: 2,4-diamino-S-triazines with a masked covalent labelling groupS M Mackenzie, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1971
Triazines and related products. 8. Potential irreversible chymotrypsin inhibitors: 3-alkyl-1,2,3-benzotriazin-4(3H)-ones and o-azidobenzamidesA C Mair, M F Stevens
Journal of Medicinal Chemistry|April 26, 2000
Structural studies on bioactive compounds. 32. Oxidation of tyrphostin protein tyrosine kinase inhibitors with hypervalent iodine reagentsG Wells, A Seaton, M F Stevens
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacy and Pharmacology|December 1, 1981
A new light on the photo-decomposition of the antitumour drug DTICJ K Horton, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Azidoacridines; potential nucleic acid mutagensA C Mair, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1973
Medicinal nitro-compounds. 1. Photo-rearrangement of N-aryl-2-nitrobenzamidesB C Gunn, M F Stevens
The Journal of Pharmacy and Pharmacology|December 1, 1979
Search for drug interactions between the antitumour agent DTIC and other cytotoxic agents [proceedings]J K Horton, M F Stevens
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
From triazines and triazenes to temozolomideM F Stevens, E S Newlands
British Medical Journal|August 27, 2010
New Stabilizer for Schick ToxinA T Glenny, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1975
Triazines and related products. Part XV. 2,4-Diaminopyrimidines and 2-aminopyrimidin-4(3H)-ones bearing 1,2,3-benzotriazinyl groups as potential dihydrofolic reductase inhibitorsT B Brown, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1972
Triazines and related products. IX. Potential irreversible dihydrofolate reductase inhibitors: 2,4-diamino-S-triazines with a masked covalent labelling groupS M Mackenzie, M F Stevens
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1971
Triazines and related products. 8. Potential irreversible chymotrypsin inhibitors: 3-alkyl-1,2,3-benzotriazin-4(3H)-ones and o-azidobenzamidesA C Mair, M F Stevens
Journal of Medicinal Chemistry|April 26, 2000
Structural studies on bioactive compounds. 32. Oxidation of tyrphostin protein tyrosine kinase inhibitors with hypervalent iodine reagentsG Wells, A Seaton, M F Stevens
Pageof 13